China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical research on molecular probes targeting acidic prostatic phosphatase (ACP3)'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133612
Registration Time: 2026/09/29
Type: Interventional study
Primary Sponsor: The First Affiliated Hospital of Guilin Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345019
Published by HT Digital Content Services with permission from Health Daily Digest....